PHGDH and cardiac hypertrophy: Among the enzymes that activate the auxiliary pathways branching from the glycolytic pathway, suppression of either GFAT, which mediates activation of the hexosamine biosynthetic pathway (29), or PHGDH, which mediates activation of the serine biosynthetic pathway (17), also inhibited YAP-induced cardiac hypertrophy.